2024 / 06

DOI: 10.24075/vrgmu.2024.074
Авторские права: © 2024 принадлежат авторам. Лицензиат: РНИМУ им. Н.И. Пирогова.
Статья размещена в открытом доступе и распространяется на условиях лицензии Creative Commons Attribution (CC BY).

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

Перспективы генной терапии гемопоэтическими стволовыми клетками

Я. М. Валиева1, К. В. Попов2
Информация об авторах

1 Московский физико-технический институт (Национальный исследовательский университет), Москва, Россия

2 Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени В. И. Кулакова, Москва, Россия

Для корреспонденции: Константин Васильевич Попов
ул. Опарина, д. 4, г. Москва, 117997, Россия; ur.liam@tsnok_vopop

Информация о статье

Финансирование: работа выполнена в рамках государственного задания Министерства здравоохранения Российской Федерации № 123020800103-6.

Вклад авторов: Я. М. Валиева — анализ литературы, сбор данных, написание рукописи. К. В. Попов — идея рукописи, редактирование рукописи.

Статья получена: 25.12.2024 Статья принята к печати: 29.12.2024 Опубликовано online: 31.12.2024
|
  1. Carvalho M, Sepodes B, Martins AP. Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework. Frontiers in Medicine [Internet]. 2017; 4. Available from: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2017.00182/full.
  2. Wang D, Gao G. State-of-the-art human gene therapy: part ii. gene therapy strategies and applications. 2014. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4440458/.
  3. CAR T Cells: Engineering Immune Cells to Treat Cancer [Internet]. Cancer gov. 2022. Available from: https://www.cancer.gov/about-cancer/treatment/research/car-t-cells.
  4. Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduction and Targeted Therapy. 2024; 9 (1). Available from: https://pubmed.ncbi.nlm.nih.gov/38565561/.
  5. Kohn DB, Booth C, Shaw KL, Xu-Bayford J, Garabedian E, Trevisan V, et al. Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency. New England Journal of Medicine. 2021; 384 (21): 2002–13. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2027675.
  6. Zhu Y, Zhu L, Wang X, Jin H. RNA-based therapeutics: an overview and prospectus. Cell Death and Disease [Internet]. 2022 Jul 23;13(7). Available from: https://www.nature.com/articles/s41419-022-05075-2
  7. Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, et al. CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduction and Targeted Therapy. 2023; 8 (1). Available from: https://www.nature.com/articles/s41392-023-01309-7.
  8. Ferrari S, Valeri E, Conti A, Scala S, Aprile A, Di Micco R, et al. Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy. Cell Stem Cell]. 2023; 30 (5): 549– 70. Available from: https://pubmed.ncbi.nlm.nih.gov/37146580/.
  9. Meaker GA, Wilkinson AC. Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions. Experimental Hematology]. 2023; 130: 104136. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11511678/.
  10. Horgan C, Watts K, Ram D, Rust S, Hutton R, Jones S, et al. A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead. JIMD Reports. 2023; 64 (5): 346–52. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jmd2.12378.
  11. Duncan CN, Bledsoe JR, Grzywacz B, Beckman A, Bonner M, Eichler FS, et al. Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy. New England Journal of Medicine. 2024; 391 (14): 1287–301. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2405541.
  12. Rabinowitz J, Chan YK, Samulski RJ. Adeno-Associated Virus (AAV) Versus Immune Response. Viruses. 2019; 11 (2): 102. Available from: https://www.mdpi.com/1999-4915/11/2/102.
  13. de Vasconcelos P, Lacerda JF. Hematopoietic Stem Cell Transplantation for Neurological Disorders: A Focus on Inborn Errors of Metabolism. Front Cell Neurosci. 2022; 16: 895511. Available from: https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2022.895511/full.
  14. Mikulska M, Gualandi F, Anserini P. Early and late complications of hematopoietic stem cell transplantation. Handb Clin Neurol. 2024; 202: 135–51.
  15. Maragkou I, Maragkou I. The most expensive drugs in the US. Pharmaceutical Technology. 2024. Available from: https://www.pharmaceutical-technology.com/features/the-most-expensive-drugs-in-the-us/.